Published in Int J Bipolar Disord on September 17, 2015
Childhood life events, immune activation and the development of mood and anxiety disorders: the TRAILS study. Transl Psychiatry (2017) 0.75
T Cell Deficits and Overexpression of Hepatocyte Growth Factor in Anti-inflammatory Circulating Monocytes of Middle-Aged Patients with Bipolar Disorder Characterized by a High Prevalence of the Metabolic Syndrome. Front Psychiatry (2017) 0.75
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry (1978) 25.54
The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med (1996) 7.70
To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav Immun (2009) 3.00
A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry (2008) 1.66
Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord (2012) 1.46
The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc Biol (2012) 1.33
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord (2009) 1.32
Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry (2013) 1.26
Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res (2013) 1.13
The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. J Affect Disord (2001) 1.11
Immune variations in bipolar disorder: phasic differences. Bipolar Disord (2007) 1.07
Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int J Neuropsychopharmacol (2010) 1.05
Neuroinflammation in bipolar disorder - A [(11)C]-(R)-PK11195 positron emission tomography study. Brain Behav Immun (2014) 1.02
Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2008) 0.94
Cytokine levels in euthymic bipolar patients. J Affect Disord (2010) 0.93
Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder. J Affect Disord (2011) 0.92
The association between immune activation and manic symptoms in patients with a depressive disorder. Transl Psychiatry (2013) 0.91
Cytokine production in bipolar affective disorder patients under lithium treatment. J Affect Disord (2004) 0.89
A preliminary report of increased plasma levels of IL-33 in bipolar disorder: further evidence of pro-inflammatory status. J Affect Disord (2014) 0.86
Clinical characteristics of inflammation-associated depression: Monocyte gene expression is age-related in major depressive disorder. Brain Behav Immun (2014) 0.83
Antiviral and immunomodulatory effect of lithium. Pharmacopsychiatry (2000) 0.82
Relationship between clinical features and inflammation-related monocyte gene expression in bipolar disorder - towards a better understanding of psychoimmunological interactions. Bipolar Disord (2013) 0.82
Monocyte activation, brain-derived neurotrophic factor (BDNF), and S100B in bipolar offspring: a follow-up study from adolescence into adulthood. Bipolar Disord (2014) 0.81